COVID Vaccine Transition Planning: Price Does Not Come Up At ACIP
• By Michael McCaughan
Despite the headlines, policymakers see considerable ongoing value in COVID vaccinations even at the planned commercial prices. • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
